相关实验视频

Updated: Jun 24, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

外体序列分析确定了与基于机器学习的冠状动脉疾病标记器相关的罕见编码变体

Ben Omega Petrazzini^1,2,3, Iain S Forrest^1,2,4, Ghislain Rocheleau^1,2,3

¹The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Nature genetics

|June 11, 2024

概括

这项研究使用了冠状动脉疾病 (CAD) 的 in silico 评分来识别与该疾病相关的遗传变异. 这些发现揭示了新的基因关联,增强了我们对CAD的理解.

科学领域:

遗传学和生物信息学
心血管疾病研究研究
计算生物学计算生物学

背景情况:

冠状动脉疾病 (CAD) 是一种复杂的疾病,受到各种风险因素和病理过程的影响.
从机器学习和电子健康记录中获得的in silico评分可以量化CAD的进展,严重程度和诊断不足.
这种数字标记物有可能改善CAD中的遗传发现.

研究的目的:

为了研究罕见和超罕见的编码变体与in silico CAD得分之间的关联.
为了确定冠状动脉疾病的新型遗传贡献者.
探索数字健康标记在遗传关联研究中的实用性.

主要方法:

利用了英国生物库,我们所有人的研究计划和BioMe生物库数据.
在罕见/极罕见的编码变体和in silico CAD得分之间进行了关联测试.
评估已识别的基因对CAD的现有遗传,生物或临床支持.

主要成果:

在17个基因中确定了与in silico CAD得分的显著关联.
验证了这些基因中的14个,此前有证据支持它们在CAD中的作用.
在321个聚合的CAD相关基因中观察到超稀有编码变异的丰富.

结论:

这项研究扩大了对冠状动脉疾病遗传基础的理解.
从电子健康记录中获得的数字标记可以有效地增强CAD等复杂疾病的遗传关联研究.
预计在CAD中进一步发现超罕见的变异关联.

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...